Investigating how a specific protein variant affects cancer and DNA damage
Mdm2 Alternative Splicing in DNA Damage and Cancer
This study is looking at a special version of a protein called MDM2 that helps control another important protein, p53, which fights cancer; researchers want to understand how this version behaves under stress and how it might be used to create better treatments for cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10911135 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of an alternative form of the MDM2 protein in regulating the p53 tumor suppressor pathway, which is crucial for preventing cancer. The study examines how this protein variant, MDM2-ALT1, is produced in response to cell stress and its dual role in promoting or inhibiting cancer progression. By using advanced techniques, researchers aim to identify the mechanisms behind MDM2-ALT1 expression and explore the potential of targeting this variant with specific therapies to improve cancer treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with specific types of cancers such as pediatric high-grade gliomas, astrocytomas, and certain adult cancers like lymphomas and breast cancer.
Not a fit: Patients with cancers not associated with MDM2-ALT1 expression or those without a diagnosis of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance the effectiveness of cancer treatments by targeting the MDM2-ALT1 protein.
How similar studies have performed: Previous research has shown promising results in targeting alternative splicing in cancer, suggesting that this approach may lead to significant advancements in treatment.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Chandler, Dawn S — Research Inst Nationwide Children's Hosp
- Study coordinator: Chandler, Dawn S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.